News in Brief
Pharmacology - Dec 6
Novartis Phase III data on new inhaled dual combination QMF149 show significant improvement across key asthma outcomes versus monotherapy
Novartis Phase III data on new inhaled dual combination QMF149 show significant improvement across key asthma outcomes versus monotherapy
wire - news in brief
Category
Results 51 - 100 of 373.
This year's Johanna Dürmüller-Bol DBMR Research Award of the Department for BioMedical Research (DBMR) of the University of Bern goes to Maria-Nieves Sanz.
The next generation of ultra high-performance fiber-reinforced concrete (UHPFRC) has just been created at EPFL. The new material will be used to strengthen bridges and other structures - both new and old. What's more, the process of manufacturing this material releases 60-70% less CO2 than the previous generation of fiber-reinforced concrete.
New Novartis PREVENT data show Cosentyx delivers early relief in axial spondyloarthritis
Patients & Caregivers Healthcare Professionals Society & ESG 42.2% of patients with non-radiographic axial spondyloarthritis (nr-axSpA) treated with Cosentyx had improved ASAS40 scores
Patients & Caregivers Healthcare Professionals Society & ESG 42.2% of patients with non-radiographic axial spondyloarthritis (nr-axSpA) treated with Cosentyx had improved ASAS40 scores
Sandoz presents real-world data showing effectiveness of Erelzi (etanercept-szzs) in rheumatic disease treatment
Patients & Caregivers Healthcare Professionals Society & ESG Interim results from COMPACT, a multi-country, real-world study of Erelzi for approved rheumatic diseases presented at 2019 ACR/AR
Patients & Caregivers Healthcare Professionals Society & ESG Interim results from COMPACT, a multi-country, real-world study of Erelzi for approved rheumatic diseases presented at 2019 ACR/AR
A chat with the expert: Luca Gambardella
The series of talks "Quattro chiacchiere con l'esperto", organised by USI Ideatorio Cadro, continues with Luca Gambardella, Director of Dalle Molle Institute for Artificial Intelligence USI-SUPSI. An informal chat with the expert about the human brain vs artificial intelligence. Computer scientist Luca Gambardella is the Director of Dalle Molle Institute for Artificial Intelligence (USI-SUPSI), for which he began working in 1988.
The series of talks "Quattro chiacchiere con l'esperto", organised by USI Ideatorio Cadro, continues with Luca Gambardella, Director of Dalle Molle Institute for Artificial Intelligence USI-SUPSI. An informal chat with the expert about the human brain vs artificial intelligence. Computer scientist Luca Gambardella is the Director of Dalle Molle Institute for Artificial Intelligence (USI-SUPSI), for which he began working in 1988.
Roche’s Gazyva (obinutuzumab), in combination with standard of care, more than doubles the percentage of lupus nephritis patients achieving complete renal response, compared to standard of care alone
Roche today announced data from the phase II NOBILITY study, investigating the safety and efficacy of Gazyva (obinutuzumab) for adults with proliferative lupus nephritis.
Roche today announced data from the phase II NOBILITY study, investigating the safety and efficacy of Gazyva (obinutuzumab) for adults with proliferative lupus nephritis.
Roche’s risdiplam meets primary endpoint in pivotal SUNFISH trial in people with type 2 or 3 spinal muscular atrophy
Roche today announced positive data from the pivotal Part 2 of SUNFISH, a study evaluating risdiplam in people aged 2-25 years with Type 2 or 3 spinal muscular atrophy (SMA).
Roche today announced positive data from the pivotal Part 2 of SUNFISH, a study evaluating risdiplam in people aged 2-25 years with Type 2 or 3 spinal muscular atrophy (SMA).
EPFL aims to build trust in fintechs
A new research program will combine the specialist knowledge of the Swiss Finance Institute @ EPFL with insights from the School's data scientists and digital trust experts.
A new research program will combine the specialist knowledge of the Swiss Finance Institute @ EPFL with insights from the School's data scientists and digital trust experts.
ETH researchers are planning to partner with clinics, foundations, public authorities and other institutions through a broad-based initiative aimed at improving the quality of life and participation of people with physical disabilities.
Dominik Hangartner, a political scientist at ETH Zurich, has received one of Switzerland's most prestigious science awards. The National Latsis Prize has recognised the quality of Hangartner's research on migration and its importance for public policy. We sat down with Hangartner to find out what drives him and what he finds so exciting about turning research into concrete policies.
EPFL's student bioengineering team has won the Grand Prize of the 2019 International Genetically Engineered Machine (iGEM) competition, as well as the Best Environment Project.
Hackers are increasingly exploiting weaknesses in IT system hardware rather than software. To close this gap, we are introducing a new open source project based on Google's Titan security technology and the "Ibex" open source processor from ETH. Luca Benini, Professor at the Institute for Integrated Systems, explains how.
Sustainable investments are on the rise, but does impact follow? The new UZH report on sustainable investing capabilities urges private banks to gear up their services to meet investor demands ' and environmental targets.
Data innovation strategy: FSO pilot projects point to productivity gains
Official statistics can benefit from new analysis methods arising from its data innovation strategy. The automation of certain tasks, especially data preparation, seems to be particularly promising. Although the first results from the FSO's pilot projects are encouraging, according to an initial assessment published on the "experimental statistics" microsite, they still need fine-tuning before they can be fully implemented in ongoing production.
Official statistics can benefit from new analysis methods arising from its data innovation strategy. The automation of certain tasks, especially data preparation, seems to be particularly promising. Although the first results from the FSO's pilot projects are encouraging, according to an initial assessment published on the "experimental statistics" microsite, they still need fine-tuning before they can be fully implemented in ongoing production.
EPFL-based startup Droople has developed a smart flow meter that can measure buildings' water consumption and identify potential savings in energy.
Novartis Cosentyx shows encouraging results versus Humira * from first-of-its-kind head-to-head trial in psoriatic arthritis
Cosentyx narrowly missed statistical significance for superiority in ACR 20, the primary endpoint of the EXCEED trial, while showing numerically higher results versus Humira * Statistically signifi
Cosentyx narrowly missed statistical significance for superiority in ACR 20, the primary endpoint of the EXCEED trial, while showing numerically higher results versus Humira * Statistically signifi
News By: Michèle Marti and Felix Würsten Twenty years ago, Switzerland ratified the Comprehensive Nuclear-Test-Ban Treaty.
Energy geostructures provide a constant source of renewable heating and cooling in buildings and infrastructures and perform very well.
The Dark Energy Spectroscopic Instrument (DESI), is a US-led project that will measure the accelerated expansion of the Universe in order to reveal the nature of dark energy. The DESI project, which has received significant contributions from EPFL's astrophysicists, is entering its final testing phase, gearing up to charter the skies.
Professor Claudia R. Binder will take over as the new dean of ENAC on 1 January 2020. We spoke with her about her plans to make the school a center of excellence in advancing the sustainability of our natural and built environment.
Novartis announces AVXS-101 intrathecal study update
FDA placed a partial hold on AVXS-101 intrathecal clinical trials for SMA patients based on findings in a small pre-clinical animal study Adverse events that might be expected from the pre-clinical f
FDA placed a partial hold on AVXS-101 intrathecal clinical trials for SMA patients based on findings in a small pre-clinical animal study Adverse events that might be expected from the pre-clinical f
Cashless payments, online maps for navigation, photo sharing on social networks - digitalisation has become an integral part of our everyday lives. But it's much less well established in urban water management. Why is that? Frank Blumensaat : Urban water management has traditionally been regarded as a conservative sector.
Roche’s marketing applications for satralizumab in neuromyelitis optica spectrum disorder accepted for review by EMA and FDA
Satralizumab represents a potential new approach to treating neuromyelitis optica spectrum disorder (NMOSD), a rare, debilitating disease often misdiagnosed as multiple sclerosis European Medicines A
Satralizumab represents a potential new approach to treating neuromyelitis optica spectrum disorder (NMOSD), a rare, debilitating disease often misdiagnosed as multiple sclerosis European Medicines A
On behalf of a German ship operator, a team from ETH Zurich mapped out "routes" towards emission-free shipping. To this end, they investigated shipping activities in the North and Baltic Seas as well as the infrastructure, costs of new fuels and storage options. Shipping currently accounts for around three percent of global CO2 emissions, which makes it one of the largest polluters in the transport industry alongside road and air transport.
For the past decade and a half, the Center for Biomedical Imaging (CIBM) has been bringing researchers and clinicians together to develop cutting-edge technologies. This anniversary is an opportunity to reflect on the Center's past successes and ponder the challenges that lie ahead in the field of medical imaging.
Hydrogen is considered a promising solution for mobility without fossil fuels. What is still missing, however, is a nation-wide network of fueling stations. One reason for this: The approval procedure for the planning and construction of hydrogen filling stations is still very confusing, as experience is largely lacking.
Empa recently founded the NMJ Association together with partner institutions from Japan, Canada, China, the USA and Germany.
More than half of internet users in Switzerland avoid searching for certain terms or expressing certain views online because they believe they are being monitored.
The first national competence centre for translational medicine and entrepreneurship has opened in Bern. As a hub for research and innovation, "sitem-insel" is home to several start-ups, companies and scientists. These include an Empa research team whose projects aim to bring medical innovations from the laboratory directly to patients more quickly.
GTX medical, an EPFL spin-off that has developed an implantable neuromodulation therapy to help people with spinal cord injuries walk again, merged today with NeuroRecovery Technologies, a US-based company, developing a transcutaneous stimulation therapy to improve upper limb function after a SCI.
News in Brief
Pharmacology - Dec 6
Novartis Phase III data on new inhaled dual combination QMF149 show significant improvement across key asthma outcomes versus monotherapy
Novartis Phase III data on new inhaled dual combination QMF149 show significant improvement across key asthma outcomes versus monotherapy